Lobe Sciences Stock Price History
LOBEF Stock | USD 0 0.0003 20.00% |
If you're considering investing in Lobe OTC Stock, it is important to understand the factors that can impact its price. As of today, the current price of Lobe Sciences stands at 0, as last reported on the 18th of December 2024, with the highest price reaching 0 and the lowest price hitting 0 during the day. Lobe Sciences is out of control given 3 months investment horizon. Lobe Sciences has Sharpe Ratio of 0.29, which conveys that the firm had a 0.29% return per unit of risk over the last 3 months. We were able to analyze and collect data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 76.0% are justified by taking the suggested risk. Use Lobe Sciences Mean Deviation of 178.25, risk adjusted performance of 0.23, and Downside Deviation of 48.43 to evaluate company specific risk that cannot be diversified away.
Lobe OTC Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Lobe |
Sharpe Ratio = 0.2864
Best Portfolio | Best Equity | LOBEF | ||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
265.35 actual daily | 96 96% of assets are less volatile |
Expected Return
5.01 actual daily | 96 96% of assets have lower returns |
Risk-Adjusted Return
0.29 actual daily | 22 78% of assets perform better |
Based on monthly moving average Lobe Sciences is performing at about 22% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Lobe Sciences by adding it to a well-diversified portfolio.
Lobe Sciences OTC Stock Price History Chart
There are several ways to analyze Lobe Stock price data. The simplest method is using a basic Lobe candlestick price chart, which shows Lobe Sciences price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | October 1, 2024 | 0.0168 |
Lowest Price | November 25, 2024 | 8.0E-4 |
Lobe Sciences December 18, 2024 OTC Stock Price Synopsis
Various analyses of Lobe Sciences' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Lobe OTC Stock. It can be used to describe the percentage change in the price of Lobe Sciences from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Lobe OTC Stock.Lobe Sciences Price Daily Balance Of Power | (0.75) | |
Lobe Sciences Price Rate Of Daily Change | 0.80 |
Lobe Sciences December 18, 2024 OTC Stock Price Analysis
Lobe OTC Stock Price History Data
The price series of Lobe Sciences for the period between Thu, Sep 19, 2024 and Wed, Dec 18, 2024 has a statistical range of 0.02 with a coefficient of variation of 130.46. The daily prices for the period are spread out with arithmetic mean of 0.0. The median price for the last 90 days is 0.0. The company underwent 1:6 stock split on 10th of June 2022.Open | High | Low | Close | Volume | ||
12/18/2024 | 0 | 0 | 0 | 0 | ||
12/16/2024 | 0 | 0 | 0 | 0 | 81,600 | |
12/13/2024 | 0 | 0 | 0 | 0 | 90,800 | |
12/12/2024 | 0 | 0 | 0 | 0 | 25,500 | |
12/11/2024 | 0 | 0 | 0 | 0 | 21,300 | |
12/10/2024 | 0 | 0 | 0 | 0 | 31,600 | |
12/09/2024 | 0 | 0 | 0 | 0 | 5,500 | |
12/06/2024 | 0 | 0 | 0 | 0 | 58,500 | |
12/05/2024 | 0 | 0 | 0 | 0 | 21,700 | |
12/04/2024 | 0 | 0 | 0 | 0 | 3,500 | |
12/03/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 8,463 | |
12/02/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 4,316 | |
11/29/2024 | 0 | 0 | 0 | 0 | 1,800 | |
11/27/2024 | 0 | 0 | 0 | 0 | 66,400 | |
11/26/2024 | 0 | 0 | 0.0009 | 0 | 145,500 | |
11/25/2024 | 0 | 0 | 0.0008 | 0.0008 | 396,600 | |
11/22/2024 | 0 | 0 | 0 | 0 | 65,400 | |
11/21/2024 | 0 | 0 | 0 | 0 | 50,200 | |
11/20/2024 | 0 | 0 | 0 | 0 | 62,200 | |
11/19/2024 | 0 | 0 | 0 | 0 | 200.00 | |
11/18/2024 | 0 | 0 | 0 | 0 | 23,400 | |
11/15/2024 | 0 | 0 | 0 | 0 | 34,700 | |
11/14/2024 | 0 | 0 | 0 | 0 | 100,100 | |
11/13/2024 | 0 | 0 | 0 | 0 | 700.00 | |
11/12/2024 | 0 | 0 | 0 | 0 | 32,000 | |
11/11/2024 | 0 | 0 | 0 | 0 | 40,400 | |
11/08/2024 | 0 | 0 | 0 | 0 | 64,700 | |
11/07/2024 | 0 | 0 | 0 | 0 | 52,000 | |
11/06/2024 | 0 | 0 | 0 | 0 | 15,800 | |
11/05/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 500.00 | |
11/04/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 2,192 | |
11/01/2024 | 0 | 0 | 0 | 0 | 6,500 | |
10/31/2024 | 0 | 0 | 0 | 0 | 11,000 | |
10/30/2024 | 0 | 0 | 0 | 0 | 2,800 | |
10/29/2024 | 0 | 0 | 0 | 0 | 81,000 | |
10/28/2024 | 0 | 0 | 0 | 0 | 4,300 | |
10/25/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 17,125 | |
10/24/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 349,733 | |
10/23/2024 | 0 | 0 | 0 | 0 | 1.00 | |
10/22/2024 | 0 | 0 | 0 | 0 | 1.00 | |
10/21/2024 | 0 | 0 | 0 | 0 | 14,300 | |
10/18/2024 | 0.02 | 0.02 | 0.01 | 0.02 | 5,671 | |
10/17/2024 | 0 | 0 | 0 | 0 | 104,500 | |
10/16/2024 | 0 | 0 | 0 | 0 | 1.00 | |
10/15/2024 | 0 | 0 | 0 | 0 | 3,000 | |
10/14/2024 | 0 | 0 | 0 | 0 | 52,600 | |
10/11/2024 | 0 | 0 | 0 | 0 | 337,900 | |
10/10/2024 | 0 | 0 | 0 | 0 | 11,700 | |
10/09/2024 | 0 | 0 | 0 | 0 | 143,200 | |
10/08/2024 | 0 | 0 | 0 | 0 | 5,800 | |
10/07/2024 | 0 | 0 | 0 | 0 | 2,300 | |
10/04/2024 | 0 | 0 | 0 | 0 | 25,800 | |
10/03/2024 | 0.02 | 0.02 | 0.01 | 0.01 | 12,052 | |
10/02/2024 | 0.02 | 0.02 | 0.02 | 0.02 | 9,250 | |
10/01/2024 | 0.02 | 0.02 | 0.02 | 0.02 | 11,120 | |
09/30/2024 | 0.01 | 0.02 | 0.01 | 0.01 | 37,965 | |
09/27/2024 | 0 | 0 | 0 | 0 | 43,400 | |
09/26/2024 | 0 | 0 | 0 | 0 | 31,500 | |
09/25/2024 | 0.01 | 0.02 | 0.01 | 0.01 | 26,979 | |
09/24/2024 | 0 | 0 | 0 | 0 | 15,600 | |
09/23/2024 | 0 | 0 | 0 | 0 | 18,500 |
About Lobe Sciences OTC Stock history
Lobe Sciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Lobe is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Lobe Sciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Lobe Sciences stock prices may prove useful in developing a viable investing in Lobe Sciences
Lobe Sciences Ltd., a life sciences company, focuses on the research and development of psychedelic medicines. The company was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. Lobe Sciences is traded on OTC Exchange in the United States.
Lobe Sciences OTC Stock Technical Analysis
Lobe Sciences technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
Did you try this?
Run Top Crypto Exchanges Now
Top Crypto ExchangesSearch and analyze digital assets across top global cryptocurrency exchanges |
All Next | Launch Module |
Lobe Sciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Lobe Sciences' price direction in advance. Along with the technical and fundamental analysis of Lobe OTC Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Lobe to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.23 | |||
Jensen Alpha | 91.85 | |||
Total Risk Alpha | 66.44 | |||
Sortino Ratio | 1.86 | |||
Treynor Ratio | (2.91) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Lobe OTC Stock analysis
When running Lobe Sciences' price analysis, check to measure Lobe Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lobe Sciences is operating at the current time. Most of Lobe Sciences' value examination focuses on studying past and present price action to predict the probability of Lobe Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lobe Sciences' price. Additionally, you may evaluate how the addition of Lobe Sciences to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Transaction History View history of all your transactions and understand their impact on performance | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |